29 Apr, 2022 09:49 AM
Highlights
* Signed Letter of Intent (LOI) with GenesisCare to support Radiopharm’s first Phase 1 trial in Australia
* Entered supply agreement with TerraPower for access to Actinium-225, ...read more
04 Apr, 2022 10:21 AM
* LRCC15 expression is produced by cancer cells AND the surrounding tumour microenvironment, but not by healthy normal tissues.
* LRRC15 production is very high in aggressive and treatment-resistan...read more
23 Mar, 2022 10:43 AM
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses...read more
18 Feb, 2022 09:30 AM
Rural Funds Group (RFF or the Group) comprises the stapled units in two Trusts, Rural Funds Trust (RFT) (ARSN 112 951 578) and RF Active (RFA) (ARSN 168 740 805) (collectively, the Trusts). The Dire...read more
10 Feb, 2022 01:57 PM
SYDNEY, Australia February 10, 2022 – Further to the announcement of the supply agreement with TerraPower released on 1 February 2022, at the request of the ASX, Radiopharm Theranostics (ASX: ...read more
02 Feb, 2022 09:51 AM
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic us...read more
02 Feb, 2022 09:45 AM
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic us...read more